RxDoctor Payments Data

Draupadi Talreja

Hematology & Oncology · Northridge, CANPI 1326073743

Payments from drug & device makers

$385,472in general payments, 2019–2025

Across 584 payments — averaging $660.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$342K
  • AMAG Pharmaceuticals, Inc.$17K
  • AstraZeneca$12K
  • Bristol Myers Squibb$5K
  • Ipsen Biopharmaceuticals, Inc$3K
  • Pharmacosmos Therapeutics Inc.$2K
  • plus $5K from 24 others

What the payments were for

  • Consulting fees$20,5035%
  • Speaking & faculty fees$286,84374%
  • Travel & lodging$65,00817%
  • Food & beverage$13,0863%
  • Education$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$385,472 in reported general payments places this provider in the 80th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Other hematology & oncology in Northridge

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →